Product Information
LAMOTRIGINE 25 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.0268 per EA under NDC 62332003731. Its NADAC has been published 435 times since Jun 6, 2018.
FDA first approved this application on Jan 13, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332003731
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LAMOTRIGINEApproval Type
Generic (ANDA)
FDA Application
ANDA090607FDA Approved
1/13/2011
TE Code
AB
On Market Since
2/5/2018
Pharmacological Classes
Price Statistics
The NADAC for LAMOTRIGINE 25 MG TABLET has been published 435 times since Jun 6, 2018, and over the history we have for it it has declined 34.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0268 per EA |
|---|---|
| All-time high | $0.0408 (Jun 13, 2018) |
| All-time low | $0.0242 (Nov 20, 2024) |
| 52-week high | $0.0306 |
| 52-week low | $0.0268 |
| Median price | $0.0317 |
| Average price | $0.0323 |
| Largest weekly change | -22.6% (Apr 17, 2024) |
| Weeks tracked | 435 |
| Tracking since | Jun 6, 2018 |
Generic Alternatives
The matcher finds 19 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lamotrigine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anti-epileptic Agent class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LAMOTRIGINE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LAMOTRIGINE 25 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.0268 per EA (NDC 62332003731), effective Sep 30, 2026.
How has the price of LAMOTRIGINE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for LAMOTRIGINE 25 MG TABLET has declined 34.3%. It has been tracked across 435 weekly CMS publications since Jun 6, 2018.
What are the highest and lowest recorded NADAC prices for LAMOTRIGINE 25 MG TABLET?
Since Jun 6, 2018, the NADAC for LAMOTRIGINE 25 MG TABLET has ranged from a low of $0.0242 (Nov 20, 2024) to a high of $0.0408 (Jun 13, 2018), with a median of $0.0317 per EA.
Are there cheaper alternatives to LAMOTRIGINE 25 MG TABLET?
19 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LAMOTRIGINE 25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures LAMOTRIGINE 25 MG TABLET?
LAMOTRIGINE 25 MG TABLET (NDC 62332003731) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.